Traphaco JSC (HOSE:TRA)

Market Cap	3.27T +6.2%
Revenue (ttm)	2.74T +16.2%
Net Income	233.37B +18.9%
EPS	5,630.09 +18.9%
Shares Out	41.45M
PE Ratio	14.03
Forward PE	n/a
Dividend	4,000.00 (5.06%)
Ex-Dividend Date	Dec 31, 2025

Volume	30,700
Average Volume	8,720
Open	78,500
Previous Close	79,000
Day's Range	78,500 - 80,000
52-Week Range	63,000 - 81,000
Beta	0.12
RSI	58.88
Earnings Date	Jul 28, 2026

About Traphaco JSC

Traphaco Joint Stock Company, together with its subsidiaries, produces and trades in pharmaceutical products, chemicals, and medical supplies and equipment in Vietnam. The company offers medical supplies; antipyretics; medicines for the hair, eyes, central neutral system, respiratory system, and liver; and other products. It is also involved in the production of medicines to treat human diseases, nutritional food products, and medicines derived from medicinal herbs; trading in medicines, pharmaceuticals, vaccines-biological products, chemicals,...

• Industry: Pharmaceutical Preparations
• Founded: 1972
• Employees: 1,546
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: TRA

Financial Performance

In 2025, Traphaco JSC's revenue was 2.66 trillion, an increase of 13.21% compared to the previous year's 2.35 trillion. Earnings were 216.79 billion, an increase of 4.98%.